The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti Peptic Ulcer Drugs Market Research Report 2025
Synopsis
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
The global Anti Peptic Ulcer Drugs market was valued at US$ 8713 million in 2023 and is anticipated to reach US$ 21380 million by 2030, witnessing a CAGR of 13.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti Peptic Ulcer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Peptic Ulcer Drugs.
Report Scope
The Anti Peptic Ulcer Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti Peptic Ulcer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti Peptic Ulcer Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eisai
Daewoong Pharmaceutical
Takeda Pharmaceutical
HeliCure
AstraZeneca
Ore Holdings
Sihuan Pharmaceutical
GlaxoSmithKline
Pfizer
Abbott Laboratories
Yuhan Corporation
Cadila Healthcare
Boehringer Ingelheim
Segment by Type
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Antibiotics
Ulcer Protective Drugs
Segment by Application
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti Peptic Ulcer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti Peptic Ulcer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
The global Anti Peptic Ulcer Drugs market was valued at US$ 8713 million in 2023 and is anticipated to reach US$ 21380 million by 2030, witnessing a CAGR of 13.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti Peptic Ulcer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Peptic Ulcer Drugs.
Report Scope
The Anti Peptic Ulcer Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti Peptic Ulcer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti Peptic Ulcer Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eisai
Daewoong Pharmaceutical
Takeda Pharmaceutical
HeliCure
AstraZeneca
Ore Holdings
Sihuan Pharmaceutical
GlaxoSmithKline
Pfizer
Abbott Laboratories
Yuhan Corporation
Cadila Healthcare
Boehringer Ingelheim
Segment by Type
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Antibiotics
Ulcer Protective Drugs
Segment by Application
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti Peptic Ulcer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti Peptic Ulcer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti Peptic Ulcer Drugs Market Overview
1.1 Product Overview and Scope of Anti Peptic Ulcer Drugs
1.2 Anti Peptic Ulcer Drugs Segment by Type
1.2.1 Global Anti Peptic Ulcer Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Proton Pump Inhibitors (PPIs)
1.2.3 Potassium-Competitive Acid Blockers (P-CAB)
1.2.4 Antacids
1.2.5 H2 Antagonists
1.2.6 Antibiotics
1.2.7 Ulcer Protective Drugs
1.3 Anti Peptic Ulcer Drugs Segment by Application
1.3.1 Global Anti Peptic Ulcer Drugs Market Value by Application: (2024-2030)
1.3.2 Gastritis
1.3.3 Gastric Ulcers
1.3.4 Duodenal Ulcers
1.3.5 Gastroesophageal Reflux Disease (GERD)
1.4 Global Anti Peptic Ulcer Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti Peptic Ulcer Drugs Revenue 2019-2030
1.4.2 Global Anti Peptic Ulcer Drugs Sales 2019-2030
1.4.3 Global Anti Peptic Ulcer Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti Peptic Ulcer Drugs Market Competition by Manufacturers
2.1 Global Anti Peptic Ulcer Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti Peptic Ulcer Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti Peptic Ulcer Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Anti Peptic Ulcer Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti Peptic Ulcer Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti Peptic Ulcer Drugs, Product Type & Application
2.7 Anti Peptic Ulcer Drugs Market Competitive Situation and Trends
2.7.1 Anti Peptic Ulcer Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti Peptic Ulcer Drugs Players Market Share by Revenue
2.7.3 Global Anti Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti Peptic Ulcer Drugs Retrospective Market Scenario by Region
3.1 Global Anti Peptic Ulcer Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti Peptic Ulcer Drugs Global Anti Peptic Ulcer Drugs Sales by Region: 2019-2030
3.2.1 Global Anti Peptic Ulcer Drugs Sales by Region: 2019-2024
3.2.2 Global Anti Peptic Ulcer Drugs Sales by Region: 2025-2030
3.3 Global Anti Peptic Ulcer Drugs Global Anti Peptic Ulcer Drugs Revenue by Region: 2019-2030
3.3.1 Global Anti Peptic Ulcer Drugs Revenue by Region: 2019-2024
3.3.2 Global Anti Peptic Ulcer Drugs Revenue by Region: 2025-2030
3.4 North America Anti Peptic Ulcer Drugs Market Facts & Figures by Country
3.4.1 North America Anti Peptic Ulcer Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti Peptic Ulcer Drugs Sales by Country (2019-2030)
3.4.3 North America Anti Peptic Ulcer Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti Peptic Ulcer Drugs Market Facts & Figures by Country
3.5.1 Europe Anti Peptic Ulcer Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti Peptic Ulcer Drugs Sales by Country (2019-2030)
3.5.3 Europe Anti Peptic Ulcer Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti Peptic Ulcer Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti Peptic Ulcer Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti Peptic Ulcer Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti Peptic Ulcer Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti Peptic Ulcer Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti Peptic Ulcer Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti Peptic Ulcer Drugs Sales by Country (2019-2030)
3.7.3 Latin America Anti Peptic Ulcer Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti Peptic Ulcer Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti Peptic Ulcer Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti Peptic Ulcer Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti Peptic Ulcer Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti Peptic Ulcer Drugs Sales by Type (2019-2030)
4.1.1 Global Anti Peptic Ulcer Drugs Sales by Type (2019-2024)
4.1.2 Global Anti Peptic Ulcer Drugs Sales by Type (2025-2030)
4.1.3 Global Anti Peptic Ulcer Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anti Peptic Ulcer Drugs Revenue by Type (2019-2030)
4.2.1 Global Anti Peptic Ulcer Drugs Revenue by Type (2019-2024)
4.2.2 Global Anti Peptic Ulcer Drugs Revenue by Type (2025-2030)
4.2.3 Global Anti Peptic Ulcer Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anti Peptic Ulcer Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti Peptic Ulcer Drugs Sales by Application (2019-2030)
5.1.1 Global Anti Peptic Ulcer Drugs Sales by Application (2019-2024)
5.1.2 Global Anti Peptic Ulcer Drugs Sales by Application (2025-2030)
5.1.3 Global Anti Peptic Ulcer Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anti Peptic Ulcer Drugs Revenue by Application (2019-2030)
5.2.1 Global Anti Peptic Ulcer Drugs Revenue by Application (2019-2024)
5.2.2 Global Anti Peptic Ulcer Drugs Revenue by Application (2025-2030)
5.2.3 Global Anti Peptic Ulcer Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anti Peptic Ulcer Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eisai
6.1.1 Eisai Corporation Information
6.1.2 Eisai Description and Business Overview
6.1.3 Eisai Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eisai Anti Peptic Ulcer Drugs Product Portfolio
6.1.5 Eisai Recent Developments/Updates
6.2 Daewoong Pharmaceutical
6.2.1 Daewoong Pharmaceutical Corporation Information
6.2.2 Daewoong Pharmaceutical Description and Business Overview
6.2.3 Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Product Portfolio
6.2.5 Daewoong Pharmaceutical Recent Developments/Updates
6.3 Takeda Pharmaceutical
6.3.1 Takeda Pharmaceutical Corporation Information
6.3.2 Takeda Pharmaceutical Description and Business Overview
6.3.3 Takeda Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda Pharmaceutical Anti Peptic Ulcer Drugs Product Portfolio
6.3.5 Takeda Pharmaceutical Recent Developments/Updates
6.4 HeliCure
6.4.1 HeliCure Corporation Information
6.4.2 HeliCure Description and Business Overview
6.4.3 HeliCure Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HeliCure Anti Peptic Ulcer Drugs Product Portfolio
6.4.5 HeliCure Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Anti Peptic Ulcer Drugs Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Ore Holdings
6.6.1 Ore Holdings Corporation Information
6.6.2 Ore Holdings Description and Business Overview
6.6.3 Ore Holdings Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ore Holdings Anti Peptic Ulcer Drugs Product Portfolio
6.6.5 Ore Holdings Recent Developments/Updates
6.7 Sihuan Pharmaceutical
6.6.1 Sihuan Pharmaceutical Corporation Information
6.6.2 Sihuan Pharmaceutical Description and Business Overview
6.6.3 Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Product Portfolio
6.7.5 Sihuan Pharmaceutical Recent Developments/Updates
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Corporation Information
6.8.2 GlaxoSmithKline Description and Business Overview
6.8.3 GlaxoSmithKline Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GlaxoSmithKline Anti Peptic Ulcer Drugs Product Portfolio
6.8.5 GlaxoSmithKline Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Corporation Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Pfizer Anti Peptic Ulcer Drugs Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Abbott Laboratories
6.10.1 Abbott Laboratories Corporation Information
6.10.2 Abbott Laboratories Description and Business Overview
6.10.3 Abbott Laboratories Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Abbott Laboratories Anti Peptic Ulcer Drugs Product Portfolio
6.10.5 Abbott Laboratories Recent Developments/Updates
6.11 Yuhan Corporation
6.11.1 Yuhan Corporation Corporation Information
6.11.2 Yuhan Corporation Anti Peptic Ulcer Drugs Description and Business Overview
6.11.3 Yuhan Corporation Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Yuhan Corporation Anti Peptic Ulcer Drugs Product Portfolio
6.11.5 Yuhan Corporation Recent Developments/Updates
6.12 Cadila Healthcare
6.12.1 Cadila Healthcare Corporation Information
6.12.2 Cadila Healthcare Anti Peptic Ulcer Drugs Description and Business Overview
6.12.3 Cadila Healthcare Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Cadila Healthcare Anti Peptic Ulcer Drugs Product Portfolio
6.12.5 Cadila Healthcare Recent Developments/Updates
6.13 Boehringer Ingelheim
6.13.1 Boehringer Ingelheim Corporation Information
6.13.2 Boehringer Ingelheim Anti Peptic Ulcer Drugs Description and Business Overview
6.13.3 Boehringer Ingelheim Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Boehringer Ingelheim Anti Peptic Ulcer Drugs Product Portfolio
6.13.5 Boehringer Ingelheim Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti Peptic Ulcer Drugs Industry Chain Analysis
7.2 Anti Peptic Ulcer Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti Peptic Ulcer Drugs Production Mode & Process
7.4 Anti Peptic Ulcer Drugs Sales and Marketing
7.4.1 Anti Peptic Ulcer Drugs Sales Channels
7.4.2 Anti Peptic Ulcer Drugs Distributors
7.5 Anti Peptic Ulcer Drugs Customers
8 Anti Peptic Ulcer Drugs Market Dynamics
8.1 Anti Peptic Ulcer Drugs Industry Trends
8.2 Anti Peptic Ulcer Drugs Market Drivers
8.3 Anti Peptic Ulcer Drugs Market Challenges
8.4 Anti Peptic Ulcer Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Anti Peptic Ulcer Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti Peptic Ulcer Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Anti Peptic Ulcer Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti Peptic Ulcer Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti Peptic Ulcer Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti Peptic Ulcer Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti Peptic Ulcer Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti Peptic Ulcer Drugs Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti Peptic Ulcer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti Peptic Ulcer Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti Peptic Ulcer Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti Peptic Ulcer Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti Peptic Ulcer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Peptic Ulcer Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti Peptic Ulcer Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti Peptic Ulcer Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti Peptic Ulcer Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Anti Peptic Ulcer Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti Peptic Ulcer Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Anti Peptic Ulcer Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti Peptic Ulcer Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Anti Peptic Ulcer Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti Peptic Ulcer Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Anti Peptic Ulcer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti Peptic Ulcer Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti Peptic Ulcer Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti Peptic Ulcer Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti Peptic Ulcer Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti Peptic Ulcer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti Peptic Ulcer Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti Peptic Ulcer Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti Peptic Ulcer Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti Peptic Ulcer Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti Peptic Ulcer Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti Peptic Ulcer Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti Peptic Ulcer Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti Peptic Ulcer Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti Peptic Ulcer Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti Peptic Ulcer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti Peptic Ulcer Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti Peptic Ulcer Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti Peptic Ulcer Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti Peptic Ulcer Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti Peptic Ulcer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Anti Peptic Ulcer Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Anti Peptic Ulcer Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti Peptic Ulcer Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Anti Peptic Ulcer Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Anti Peptic Ulcer Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Anti Peptic Ulcer Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Anti Peptic Ulcer Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti Peptic Ulcer Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti Peptic Ulcer Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Anti Peptic Ulcer Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Anti Peptic Ulcer Drugs Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Anti Peptic Ulcer Drugs Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Anti Peptic Ulcer Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Anti Peptic Ulcer Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Anti Peptic Ulcer Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Anti Peptic Ulcer Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Anti Peptic Ulcer Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti Peptic Ulcer Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti Peptic Ulcer Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Anti Peptic Ulcer Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Anti Peptic Ulcer Drugs Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Anti Peptic Ulcer Drugs Price (USD/Pcs) by Application (2025-2030)
Table 70. Eisai Corporation Information
Table 71. Eisai Description and Business Overview
Table 72. Eisai Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Eisai Anti Peptic Ulcer Drugs Product
Table 74. Eisai Recent Developments/Updates
Table 75. Daewoong Pharmaceutical Corporation Information
Table 76. Daewoong Pharmaceutical Description and Business Overview
Table 77. Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Product
Table 79. Daewoong Pharmaceutical Recent Developments/Updates
Table 80. Takeda Pharmaceutical Corporation Information
Table 81. Takeda Pharmaceutical Description and Business Overview
Table 82. Takeda Pharmaceutical Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Takeda Pharmaceutical Anti Peptic Ulcer Drugs Product
Table 84. Takeda Pharmaceutical Recent Developments/Updates
Table 85. HeliCure Corporation Information
Table 86. HeliCure Description and Business Overview
Table 87. HeliCure Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. HeliCure Anti Peptic Ulcer Drugs Product
Table 89. HeliCure Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. AstraZeneca Anti Peptic Ulcer Drugs Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Ore Holdings Corporation Information
Table 96. Ore Holdings Description and Business Overview
Table 97. Ore Holdings Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Ore Holdings Anti Peptic Ulcer Drugs Product
Table 99. Ore Holdings Recent Developments/Updates
Table 100. Sihuan Pharmaceutical Corporation Information
Table 101. Sihuan Pharmaceutical Description and Business Overview
Table 102. Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Product
Table 104. Sihuan Pharmaceutical Recent Developments/Updates
Table 105. GlaxoSmithKline Corporation Information
Table 106. GlaxoSmithKline Description and Business Overview
Table 107. GlaxoSmithKline Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. GlaxoSmithKline Anti Peptic Ulcer Drugs Product
Table 109. GlaxoSmithKline Recent Developments/Updates
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. Pfizer Anti Peptic Ulcer Drugs Product
Table 114. Pfizer Recent Developments/Updates
Table 115. Abbott Laboratories Corporation Information
Table 116. Abbott Laboratories Description and Business Overview
Table 117. Abbott Laboratories Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. Abbott Laboratories Anti Peptic Ulcer Drugs Product
Table 119. Abbott Laboratories Recent Developments/Updates
Table 120. Yuhan Corporation Corporation Information
Table 121. Yuhan Corporation Description and Business Overview
Table 122. Yuhan Corporation Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 123. Yuhan Corporation Anti Peptic Ulcer Drugs Product
Table 124. Yuhan Corporation Recent Developments/Updates
Table 125. Cadila Healthcare Corporation Information
Table 126. Cadila Healthcare Description and Business Overview
Table 127. Cadila Healthcare Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 128. Cadila Healthcare Anti Peptic Ulcer Drugs Product
Table 129. Cadila Healthcare Recent Developments/Updates
Table 130. Boehringer Ingelheim Corporation Information
Table 131. Boehringer Ingelheim Description and Business Overview
Table 132. Boehringer Ingelheim Anti Peptic Ulcer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 133. Boehringer Ingelheim Anti Peptic Ulcer Drugs Product
Table 134. Boehringer Ingelheim Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Anti Peptic Ulcer Drugs Distributors List
Table 138. Anti Peptic Ulcer Drugs Customers List
Table 139. Anti Peptic Ulcer Drugs Market Trends
Table 140. Anti Peptic Ulcer Drugs Market Drivers
Table 141. Anti Peptic Ulcer Drugs Market Challenges
Table 142. Anti Peptic Ulcer Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti Peptic Ulcer Drugs
Figure 2. Global Anti Peptic Ulcer Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti Peptic Ulcer Drugs Market Share by Type in 2023 & 2030
Figure 4. Proton Pump Inhibitors (PPIs) Product Picture
Figure 5. Potassium-Competitive Acid Blockers (P-CAB) Product Picture
Figure 6. Antacids Product Picture
Figure 7. H2 Antagonists Product Picture
Figure 8. Antibiotics Product Picture
Figure 9. Ulcer Protective Drugs Product Picture
Figure 10. Global Anti Peptic Ulcer Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Anti Peptic Ulcer Drugs Market Share by Application in 2023 & 2030
Figure 12. Gastritis
Figure 13. Gastric Ulcers
Figure 14. Duodenal Ulcers
Figure 15. Gastroesophageal Reflux Disease (GERD)
Figure 16. Global Anti Peptic Ulcer Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Anti Peptic Ulcer Drugs Market Size (2019-2030) & (US$ Million)
Figure 18. Global Anti Peptic Ulcer Drugs Sales (2019-2030) & (K Units)
Figure 19. Global Anti Peptic Ulcer Drugs Average Price (USD/Pcs) & (2019-2030)
Figure 20. Anti Peptic Ulcer Drugs Report Years Considered
Figure 21. Anti Peptic Ulcer Drugs Sales Share by Manufacturers in 2023
Figure 22. Global Anti Peptic Ulcer Drugs Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Anti Peptic Ulcer Drugs Players: Market Share by Revenue in 2023
Figure 24. Anti Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Anti Peptic Ulcer Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Anti Peptic Ulcer Drugs Sales Market Share by Country (2019-2030)
Figure 27. North America Anti Peptic Ulcer Drugs Revenue Market Share by Country (2019-2030)
Figure 28. U.S. Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Anti Peptic Ulcer Drugs Sales Market Share by Country (2019-2030)
Figure 31. Europe Anti Peptic Ulcer Drugs Revenue Market Share by Country (2019-2030)
Figure 32. Germany Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Anti Peptic Ulcer Drugs Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Anti Peptic Ulcer Drugs Revenue Market Share by Region (2019-2030)
Figure 39. China Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Taiwan Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Indonesia Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Thailand Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Malaysia Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Philippines Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America Anti Peptic Ulcer Drugs Sales Market Share by Country (2019-2030)
Figure 50. Latin America Anti Peptic Ulcer Drugs Revenue Market Share by Country (2019-2030)
Figure 51. Mexico Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Anti Peptic Ulcer Drugs Revenue Market Share by Country (2019-2030)
Figure 56. Turkey Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. U.A.E Anti Peptic Ulcer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of Anti Peptic Ulcer Drugs by Type (2019-2030)
Figure 60. Global Revenue Market Share of Anti Peptic Ulcer Drugs by Type (2019-2030)
Figure 61. Global Anti Peptic Ulcer Drugs Price (USD/Pcs) by Type (2019-2030)
Figure 62. Global Sales Market Share of Anti Peptic Ulcer Drugs by Application (2019-2030)
Figure 63. Global Revenue Market Share of Anti Peptic Ulcer Drugs by Application (2019-2030)
Figure 64. Global Anti Peptic Ulcer Drugs Price (USD/Pcs) by Application (2019-2030)
Figure 65. Anti Peptic Ulcer Drugs Value Chain
Figure 66. Anti Peptic Ulcer Drugs Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
